FDAnews
www.fdanews.com/articles/113663-epicept-to-end-drug-discovery-efforts-cut-65-percent-of-jobs

EpiCept to End Drug-Discovery Efforts, Cut 65 Percent of Jobs

January 12, 2009
EpiCept Corp., the Tarrytown, N.Y., drugmaker, said that it is ending its drug-discovery activity, cutting 65% of its workforce, and focusing on registering Ceplene for marketing in the U.S. and Canada and on clinical-development programs.
MarketWatch